Close Menu
Home › CareDx AlloSure Kidney, Heart Tests Garner Palmetto Draft LCD

CareDx AlloSure Kidney, Heart Tests Garner Palmetto Draft LCD

Aug 22, 2019
|
staff reporter

NEW YORK – Medicare contractor Palmetto GBA has issued a draft local coverage determination for two indications of CareDx's AlloSure, a non-invasive blood test that measures transplant injury via donor-derived cell-free DNA.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

What's Popular?

In Molecular Diagnostics

  1. Diagnostics Developers Leap Into Action on Novel Coronavirus Tests

    Premium

  2. QuantuMDx Raises $14M to Support Development of POC Genotyping Assay

  3. Colon Cancer Biomarker Undertesting Rates in Real-World Data Points to Precision Oncology Barriers

    Premium

  4. Co-Diagnostics Selling $5M of Shares

  5. Adaptive Biotechnologies Prices Public Offering of Stock

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.